Full Text View
Tabular View
No Study Results Posted
Related Studies
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
This study has been terminated.
( Due to poor accrual of the study )
Study NCT00564720   Information provided by Hellenic Oncology Research Group

First Received on November 27, 2007.   Last Updated on February 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial